Seres Therapeutics, Inc.
NASDAQ:MCRB
0.7152 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2016 Q1 | 2015 Q4 | 2015 Q3 | 2015 Q2 | 2015 Q1 | 2014 Q4 | 2014 Q3 | 2014 Q2 | 2014 Q1 | 2013 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0.064 | 0.31 | 126.473 | -0.522 | 0.975 | 3.444 | 1.216 | 1.493 | 7.221 | 126.725 | 5.263 | 5.718 | 17.564 | 1.417 | 6.045 | 8.189 | 7.622 | 7.031 | 12.531 | 7.321 | 10.629 | 9.055 | 4.612 | 3.971 | 3.056 | 23.015 | 3.014 | 3.015 | 3.036 | 13.015 | 3.004 | 2.71 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 1.42 | 1.559 | 4.053 | 0.519 | 2.106 | 3.607 | 1.004 | 43.116 | 43.935 | 0.976 | 36.752 | 1.127 | 35.954 | 29.303 | 24.867 | 23.861 | 20.099 | 21.743 | 21.032 | 18.317 | 17.905 | 22.887 | 24.767 | 23.675 | 24.053 | 23.46 | 24.042 | 22.21 | 23.06 | 20.143 | 20.256 | 24.143 | 22.174 | 15.416 | 13.9 | 9.85 | 8.784 | 5.561 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| -1.42 | -1.559 | -3.989 | -0.209 | 124.367 | -4.129 | -0.029 | -39.672 | -42.719 | 0.517 | -29.531 | 125.598 | -30.691 | -23.585 | -7.303 | -22.444 | -14.054 | -13.554 | -13.41 | -11.286 | -5.374 | -15.566 | -14.138 | -14.62 | -19.441 | -19.489 | -20.986 | 0.805 | -20.046 | -17.128 | -17.22 | -11.128 | -19.17 | -12.706 | -13.9 | -9.85 | -8.784 | -5.561 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | -62.328 | -0.674 | 0.983 | 7.91 | -0.03 | -11.519 | -35.131 | 0.346 | -4.09 | 0.991 | -5.831 | -4.125 | -0.416 | -15.839 | -2.325 | -1.655 | -1.759 | -1.605 | -0.429 | -2.126 | -1.33 | -1.615 | -4.215 | -4.908 | -6.867 | 0.035 | -6.651 | -5.681 | -5.672 | -0.855 | -6.381 | -4.689 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 17.875 | 21.702 | 26.846 | 28.253 | 46.792 | 43.969 | 46.22 | 43.116 | 43.935 | 39.649 | 36.752 | 39.882 | 35.954 | 29.303 | 24.867 | 23.861 | 20.099 | 21.743 | 21.032 | 18.317 | 17.905 | 22.887 | 24.767 | 23.675 | 24.053 | 23.46 | 24.042 | 22.21 | 23.06 | 20.143 | 20.256 | 24.143 | 22.174 | 15.416 | 13.9 | 9.85 | 8.784 | 5.561 | 5.06 | 2.466 | 2.16 | 1.032 | 1.517 |
| General & Administrative Expenses
| 16.059 | 15.466 | 17.234 | 19.989 | 28.051 | 22.47 | 22.404 | 18.384 | 20.335 | 18.571 | 20.506 | 19.563 | 17.451 | 11.741 | 10.595 | 7.551 | 6.491 | 6.138 | 5.782 | 5.897 | 5.574 | 7.495 | 7.533 | 7.591 | 8.695 | 8.777 | 8.789 | 8.119 | 8.37 | 8.762 | 8.453 | 7.967 | 8.97 | 7.21 | 5.888 | 4.711 | 3.556 | 2.606 | 2.153 | 1.113 | 0.458 | 0.64 | 0.388 |
| Selling & Marketing Expenses
| -1.42 | -1.559 | -4.053 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 14.639 | 13.907 | 13.181 | 19.989 | 28.051 | 22.47 | 22.404 | 18.384 | 20.335 | 18.571 | 20.506 | 19.563 | 17.451 | 11.741 | 10.595 | 7.551 | 6.491 | 6.138 | 5.782 | 5.897 | 5.574 | 7.495 | 7.533 | 7.591 | 8.695 | 8.777 | 8.789 | 8.119 | 8.37 | 8.762 | 8.453 | 7.967 | 8.97 | 7.21 | 5.888 | 4.711 | 3.556 | 2.606 | 2.153 | 1.113 | 0.458 | 0.64 | 0.388 |
| Other Expenses
| 0.692 | 2.468 | 0.336 | 0.999 | -1.511 | 3.607 | 0.658 | -0.033 | -0.304 | -0.976 | -0.316 | -0.035 | -0.285 | -0.409 | -0.208 | 0.345 | 0.476 | 0.368 | 0.627 | 0.439 | 0 | 1.492 | 0 | 0 | 0 | 0 | 1.124 | -0.123 | -0.217 | -0.359 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 32.514 | 35.609 | 40.027 | 47.723 | 76.949 | 70.046 | 69.282 | 62.551 | 64.541 | 57.244 | 56.653 | 58.318 | 53.405 | 41.044 | 35.462 | 31.412 | 26.59 | 27.881 | 26.814 | 24.214 | 23.479 | 30.382 | 32.3 | 31.266 | 32.748 | 32.237 | 32.831 | 30.329 | 31.43 | 28.905 | 28.709 | 32.11 | 31.144 | 22.626 | 19.788 | 14.561 | 12.34 | 8.167 | 7.213 | 3.579 | 2.618 | 1.672 | 1.913 |
| Operating Income
| -33.934 | -37.168 | -44.016 | -47.413 | 49.524 | -70.568 | -68.307 | -59.107 | -63.325 | -55.751 | -49.432 | 68.407 | -48.142 | -35.326 | -17.898 | -29.995 | -20.545 | -19.692 | -19.192 | -17.183 | -10.948 | -24.553 | -21.671 | -22.211 | -28.136 | -28.266 | -29.775 | -7.314 | -28.416 | -25.89 | -25.673 | -19.095 | -28.14 | -19.916 | -19.788 | -14.561 | -12.34 | -8.167 | -7.213 | -3.579 | -2.618 | -1.672 | -1.905 |
| Operating Income Ratio
| 0 | 0 | -687.75 | -152.945 | 0.392 | 135.188 | -70.058 | -17.162 | -52.076 | -37.342 | -6.846 | 0.54 | -9.147 | -6.178 | -1.019 | -21.168 | -3.399 | -2.405 | -2.518 | -2.444 | -0.874 | -3.354 | -2.039 | -2.453 | -6.101 | -7.118 | -9.743 | -0.318 | -9.428 | -8.587 | -8.456 | -1.467 | -9.368 | -7.349 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 1.064 | -2.965 | 2.768 | 0.999 | -1.511 | -0.606 | -0.489 | -0.033 | -0.304 | -0.873 | -0.316 | -0.035 | -0.285 | -0.409 | -0.208 | 0.345 | 0.476 | 0.368 | 0.627 | 0.439 | 0.189 | -1.492 | 0.384 | 0.262 | 0.349 | 0.347 | 1.124 | -0.123 | -0.217 | -0.359 | 0.397 | 0.407 | 0.227 | 0.212 | 0.154 | -0.059 | -0.22 | 0.213 | -0.914 | -0.521 | -0.003 | 0.02 | -0.044 |
| Income Before Tax
| -32.87 | -40.133 | -41.248 | -47.854 | 46.552 | -71.174 | -68.796 | -60.002 | -64.735 | -56.624 | -50.001 | 68.218 | -48.33 | -35.465 | -18.252 | -30.28 | -20.714 | -19.881 | -18.778 | -16.409 | -10.759 | -24.333 | -21.287 | -21.949 | -27.787 | -27.919 | -28.953 | -6.935 | -28.018 | -25.474 | -25.276 | -18.688 | -27.913 | -19.704 | -19.634 | -14.62 | -12.555 | -7.971 | -8.182 | -4.161 | -2.677 | -1.689 | -1.949 |
| Income Before Tax Ratio
| 0 | 0 | -644.5 | -154.368 | 0.368 | 136.349 | -70.56 | -17.422 | -53.236 | -37.926 | -6.924 | 0.538 | -9.183 | -6.202 | -1.039 | -21.369 | -3.427 | -2.428 | -2.464 | -2.334 | -0.859 | -3.324 | -2.003 | -2.424 | -6.025 | -7.031 | -9.474 | -0.301 | -9.296 | -8.449 | -8.325 | -1.436 | -9.292 | -7.271 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| -0 | 1.516 | -2.195 | 1.44 | 0.149 | 0.606 | 0.489 | 1.694 | 1.197 | 0.873 | -5.082 | 0.709 | 0.447 | 0.287 | 0.551 | 1.075 | 1.195 | 1.084 | -0.98 | -0.335 | 0 | 1.272 | 0 | 0 | 0 | 0 | 0.302 | -0.502 | -0.615 | -2.505 | 0.746 | 0.719 | 0.495 | 0.268 | 0.631 | -0.182 | 0.095 | -0.196 | 0.969 | 0.582 | 0.059 | 0.017 | 0.221 |
| Net Income
| -32.87 | -40.133 | -41.248 | -47.854 | 46.552 | -71.78 | -69.285 | -60.002 | -64.735 | -57.497 | -50.001 | 68.218 | -48.33 | -35.465 | -18.252 | -30.28 | -20.714 | -19.881 | -18.778 | -16.409 | -10.759 | -24.333 | -21.287 | -21.949 | -27.787 | -27.919 | -28.953 | -6.935 | -28.018 | -25.474 | -25.276 | -18.688 | -27.913 | -19.704 | -19.634 | -14.62 | -12.555 | -7.971 | -8.182 | -4.161 | -2.677 | -1.689 | -2.17 |
| Net Income Ratio
| 0 | 0 | -644.5 | -154.368 | 0.368 | 137.51 | -71.062 | -17.422 | -53.236 | -38.511 | -6.924 | 0.538 | -9.183 | -6.202 | -1.039 | -21.369 | -3.427 | -2.428 | -2.464 | -2.334 | -0.859 | -3.324 | -2.003 | -2.424 | -6.025 | -7.031 | -9.474 | -0.301 | -9.296 | -8.449 | -8.325 | -1.436 | -9.292 | -7.271 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.22 | -0.27 | -0.32 | -0.37 | 0.36 | -0.57 | -0.55 | -0.49 | -0.7 | -0.62 | -0.54 | 0.74 | -0.53 | -0.39 | -0.22 | -0.36 | -0.28 | -0.28 | -0.27 | -0.23 | -0.24 | -0.59 | -0.52 | -0.54 | -0.68 | -0.69 | -0.71 | -0.17 | -0.69 | -0.63 | -0.63 | -0.46 | -0.7 | -0.5 | -0.5 | -0.38 | -1.45 | -0.22 | -0.27 | -0.14 | -0.09 | -0.057 | -0.33 |
| EPS Diluted
| -0.22 | -0.27 | -0.32 | -0.37 | 0.36 | -0.57 | -0.55 | -0.49 | -0.7 | -0.62 | -0.53 | 0.72 | -0.53 | -0.39 | -0.22 | -0.36 | -0.28 | -0.28 | -0.27 | -0.23 | -0.24 | -0.59 | -0.52 | -0.54 | -0.68 | -0.69 | -0.71 | -0.17 | -0.69 | -0.63 | -0.63 | -0.46 | -0.7 | -0.5 | -0.5 | -0.38 | -1.45 | -0.22 | -0.27 | -0.14 | -0.09 | -0.057 | -0.33 |
| EBITDA
| -32.514 | -35.609 | -39.963 | -43.842 | 49.739 | -67.826 | -65.289 | -56.528 | -61.549 | -54.142 | -47.711 | 70.455 | -46.172 | -33.293 | -15.984 | -27.974 | -18.304 | -17.363 | -18.585 | -15.307 | -9.562 | -19.028 | -19.678 | -20.237 | -26.182 | -26.325 | -27.872 | -5.448 | -26.656 | -25.89 | -23.233 | -17.125 | -26.771 | -19.262 | -18.823 | -14.561 | -12.12 | -8.288 | -6.222 | -3.011 | -2.579 | -1.662 | -1.879 |
| EBITDA Ratio
| 0 | 0 | -624.422 | -141.426 | 0.393 | 129.935 | -66.963 | -16.413 | -50.616 | -36.264 | -6.607 | 0.556 | -8.773 | -5.822 | -0.91 | -19.742 | -3.028 | -2.12 | -2.438 | -2.177 | -0.763 | -2.599 | -1.851 | -2.235 | -5.677 | -6.629 | -9.12 | -0.237 | -8.844 | -8.587 | -7.653 | -1.316 | -8.912 | -7.108 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |